Anti-inflammatory Effects of Homotaurine in Patients With Amnestic Mild Cognitive Impairment
Alzheimer’s disease (AD) is a fatal dementing neurodegenerative disease, currently lacking an efficacious disease-modifying therapy. In the last years, there has been some interest in the use of homotaurine as a potential therapeutic compound for AD, but more work is still needed to prove its effica...
Main Authors: | Paola Bossù, Francesca Salani, Antonio Ciaramella, Eleonora Sacchinelli, Alessandra Mosca, Nerisa Banaj, Francesca Assogna, Maria Donata Orfei, Carlo Caltagirone, Walter Gianni, Gianfranco Spalletta |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-11-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnagi.2018.00285/full |
Similar Items
-
Influence of APOE and RNF219 on Behavioral and Cognitive Features of Female Patients Affected by Mild Cognitive Impairment or Alzheimer’s Disease
by: Alessandra Mosca, et al.
Published: (2018-04-01) -
A Review on Tramiprosate (Homotaurine) in Alzheimer's Disease and Other Neurocognitive Disorders
by: Sagrario Manzano, et al.
Published: (2020-07-01) -
White matter hyperintensities segmentation: a new semi-automated method
by: Mariangela eIorio, et al.
Published: (2013-12-01) -
High serum levels of transforming growth factor β1 are associated with increased cortical thickness in cingulate and right frontal areas in healthy subjects
by: Piras Fabrizio, et al.
Published: (2012-02-01) -
A Survey for Examining the Effects of COVID-19 and Infection Control Measures in Older Persons With Mild Cognitive Impairment and Dementia and Their Caregivers
by: Desirée E. Porcari, et al.
Published: (2020-11-01)